Autor:
Rolle, Augusto.
Paredes, S.
Cortínez Fernández, Luis Ignacio.
Quezada, Nicolás.
Solari Gajardo, Sandra.
Allende, Fidel.
Torres Fuentes, Jorge Luis Alejandro.
Cabrera García, Daniel Alejandro.
Contreras Ibacache, Víctor.
Carmona, J.
Background: Obesity has been associated with reduced dexmedetomidine clearance, suggesting impaired hepatic function or reduced hepatic blood flow. The aim of this study was to clarify the effect of obesity in dexmedetomidine metabolic clearance. Methods: Forty patients, ASA IeIII, 18e60 yr old, ...
Enlace original:
https://repositorio.uc.cl/handle/11534/29394
Rolle, Augusto.
,
Paredes, S.
,
Cortínez Fernández, Luis Ignacio.
,
Quezada, Nicolás.
,
Solari Gajardo, Sandra.
,
Allende, Fidel.
,
Torres Fuentes, Jorge Luis Alejandro.
,
Cabrera García, Daniel Alejandro.
,
Contreras Ibacache, Víctor.
,
Carmona, J.
,
[Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients.]
,
Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients.
